LOS ANGELES--(BUSINESS WIRE)--The Forest Road Company (Forest Road) announced today that Bill Burkoth has joined the firm’s asset management business as Managing Partner of Life Sciences.
Mr. Burkoth brings a wealth of expertise to this new venture, with over 20 years of life science venture capital investing and startup experience.
Prior to joining Forest Road, Mr. Burkoth served as the Life Science and Healthcare Managing Partner at SVB Capital within Silicon Valley Bank. In this role, he was responsible for overseeing financing to both emerging and established companies operating within the life sciences and healthcare sectors.
Prior to SVB, Mr. Burkoth was a Founder and Senior Partner at Pfizer Ventures, managing venture capital investments in healthcare related companies, leading the execution, management, and eventual exits of these investments. Bill previously led investments and served on the board of NeuMoDx Molecular, Novocure, Reflexion Medical, Palleon Pharmaceuticals, among others.
Zachary Tarica, CEO of Forest Road, said: “We are thrilled to have Bill join our team as we expand into the life sciences sector and believe he will significantly contribute to the long-term growth of the firm. His deep scientific expertise and proven track record, combined with our credit-focused approach, uniquely position us to capitalize on exciting opportunities in this rapidly growing sector.”
About The Forest Road Company
Forest Road is a next-generation merchant bank that operates investment and advisory platforms while also being an active investor on a principal basis. Led by a team of experienced investors, operators, and advisors, Forest Road offers a differentiated value proposition to its partners, supported by its unique investing perspective and flexible mandates. Forest Road embraces complexity and creativity to extract value where others see limitations, opportunistically investing in disrupted sectors. For more information, visit www.forestroadco.com.
